{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-074990","form_type":"8-K","ticker":"SPRB","cik":"0001683553","company_name":"SPRUCE BIOSCIENCES, INC.","filed_at":"2024-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.575325+00:00","generated_at":"2026-06-01T03:55:24.265680+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Spruce Biosciences designated back-up bidder for Avexitide assets, net purchase price $34.7M","bullets":["Entered stalking horse agreement June 13 for Avexitide assets; initial purchase price $10M.","After auction June 17, Spruce became back-up bidder; net purchase price $34.7M (after $0.3M fee credit).","Sale to winning bidder subject to Bankruptcy Court approval at hearing scheduled June 26, 2024.","If winning bidder fails to close, Spruce must acquire assets; otherwise receives $0.3M termination fee.","Spruce also assumes specified contractual cure amounts up to $0.3M if it becomes buyer."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-074990","json":"https://secwatch.observer/filing/0000950170-24-074990.json","markdown":"https://secwatch.observer/filing/0000950170-24-074990.md","text":"https://secwatch.observer/filing/0000950170-24-074990.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1683553/000095017024074990/0000950170-24-074990-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1683553/000095017024074990/sprb-20240613.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:55:24.265680+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}